about
Considerations on the Mechanism of Action of Artemisinin Antimalarials: Part 1 - The 'Carbon Radical' and 'Heme' HypothesesHIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsNew approaches to structure-based discovery of dengue protease inhibitors.New Drug Targets for Hepatitis C and Other Flaviviridae VirusesUnraveling effector functions of B cells during infection: the hidden world beyond antibody productionA technological update of molecular diagnostics for infectious diseasesStructural genomics and drug discovery for infectious diseasesAscaris lumbricoides: an overview of therapeutic targetsEvolutionary and functional relationships of B cells from fish and mammals: insights into their novel roles in phagocytosis and presentation of particulate antigenBenefits of structural genomics for drug discovery researchAntiviral strategies against human coronaviruses.Influenza viruses: basic biology and potential drug targets.Reconstruction of the 1918 pandemic influenza virus: how revealing the molecular secrets of the virus responsible for the worst pandemic in recorded history can guide our response to future influenza pandemics.Pandemic influenza: preventing the emergence of novel strains and countermeasures to ameliorate its effects.Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic.Influenza virus hemagglutinin--structural studies and their implications for the development of therapeutic approaches.Diabetes care: risk factors, prediction, prevention, and individualized treatment.Epidemiology, prevention, and management of influenza in patients with hematologic malignancy.Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectives.Descriptive Analysis of Mortality Predictors in H1n1 Influenza in South Indian Patients.Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.Oseltamivir pharmacology in young children: a commentary.Oseltamivir in neonates, infants and young children: a focus on clinical pharmacology.Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.Oseltamivir use in adolescents and adults: clinical and economic considerations.Mass spectrometry-based proteomics and its application to studies of Porphyromonas gingivalis invasion and pathogenicity.Epidemiology and prevention of bacterial infections in patients with hematologic malignancies.High-throughput identification of conditionally essential genes in bacteria: from STM to TSM.In vivo induced antigen technology (IVIAT) and change mediated antigen technology (CMAT).Mass spectrometry-based approaches for the detection of proteins of Staphylococcus species.Amyloidophilic compounds for prion diseases.The Clinico-hematological features and management outcome in neonatal malaria : A nine years analysis from North India.Antimalarial drug discovery: in silico structural biology and rational drug design.Cyclospora cayetanensis: a review, focusing on some of the remaining questions about cyclosporiasis.The Seattle Structural Genomics Center for Infectious Disease (SSGCID).Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.Infectious burden: a new risk factor and treatment target for atherosclerosis.Virus vasculopathy and stroke: an under-recognized cause and treatment target.Giardiasis: the ever-present threat of a neglected disease.
P1433
Q22061777-DA6980F6-8189-4EE4-B355-B398A1B9AF50Q22241321-A330F724-B830-4676-9E0F-AB00571925ECQ22305777-79313BB8-400E-4285-B944-FA3D5708957EQ22336980-7CA9CA10-665A-418A-9758-D440323CF7C8Q27010202-497638A1-514A-4268-88CB-5308E6FCA2A0Q27487056-907E7075-9E30-49FA-B1E6-FF62C08DFA48Q27490495-769401A1-4601-45C4-B3F9-C61590FA3AB2Q28290195-DE7DE148-52E5-4178-A99A-A8FC488C0781Q28728395-76ECD681-76A9-4395-8ED5-203DD115DFAAQ28752276-F62BB2F3-326B-40AD-9C06-7C2195D9DE3AQ30360255-007B9ED6-A29C-42E4-98D4-D1355E4DA8C4Q30367378-DA55E3E9-4241-434C-A280-907ED03514D0Q30367381-4D1B9FEC-E818-474A-9EF8-B156ADC5785EQ30367383-A19F3C5A-89F0-4B74-BD6E-DF50BCFB5321Q30367385-BF9127EE-F247-4187-84BA-E2ED667C4ED1Q30367389-DA442A96-5A1A-433C-BE1E-485DE19AFBB9Q30369824-ECA2F13A-11E8-43FC-849A-090D4821B2C7Q30399450-9047A86B-37D0-4CED-9BB8-FD997C20B7D6Q30400765-FACD7CDA-A7B5-44AE-856D-9E24BE167712Q30401025-AF859ACC-59E6-44E0-8B6E-9A6AEF1D50D9Q30421709-EE5506C4-388B-497A-87C6-27C19C612FF6Q30430554-E4C8E20B-0369-40AC-AB2E-37EE9A49F0A7Q30430558-FF144643-9FAF-4B0E-A559-24582679B7C4Q30430563-9C04DE2A-1574-4DCF-909A-B41F148B0D12Q30430567-BF57F19E-3DBB-4556-BB89-183E12E57519Q30430571-132AEB2C-48CF-4250-97A7-9466E634A8BBQ30439892-2D04DC39-DF24-4705-9D77-F98502227EAAQ30452830-7B56ADF5-3563-4DB2-85B1-1FB901533507Q33254420-44BA5D01-30CD-4891-90EF-06F567AC9BF6Q33254422-E64E9100-BC47-4E8F-AB9E-38204A3C03CBQ33368220-27F7B861-6B01-48AC-97DF-308B60990518Q33406577-9957C85A-64C3-47F8-928F-315E06A936E8Q33436243-C6468920-4C5D-4666-B6CC-B70B9FDD6F86Q33466461-7B1321AC-DE9A-4EC5-B196-57E0B13D46BFQ33654611-C5322911-4BF3-4D7D-8A42-C45B3A2DCBB1Q33802114-8529B8E5-0D9B-4AE4-A9E0-91CF65380482Q33903812-27F71FF2-B961-409F-B974-5AB9BA854A91Q33936406-4ED43BB1-7FC2-4077-ACDA-1441166A64F2Q34015853-7DA761C2-752E-477C-9843-5447984D8FD9Q34130778-6EFE7A16-FC41-4A62-B2B6-3BB4268A47C8
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
name
Infectious disorders drug targets
@ast
Infectious disorders drug targets
@en
Infectious disorders drug targets
@es
Infectious disorders drug targets
@it
Infectious disorders drug targets
@nl
type
label
Infectious disorders drug targets
@ast
Infectious disorders drug targets
@en
Infectious disorders drug targets
@es
Infectious disorders drug targets
@it
Infectious disorders drug targets
@nl
prefLabel
Infectious disorders drug targets
@ast
Infectious disorders drug targets
@en
Infectious disorders drug targets
@es
Infectious disorders drug targets
@it
Infectious disorders drug targets
@nl
P3181
P1055
P1058
P1156
4600151527
P1250
P1476
Infectious disorders drug targets
@en